MENU
+Compare
VERV
Stock ticker: NASDAQ
AS OF
Apr 25 closing price
Price
$5.76
Change
-$0.02 (-0.35%)
Capitalization
511.46M

VERV Verve Therapeutics Forecast, Technical & Fundamental Analysis

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines... Show more

VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for VERV with price predictions
Apr 25, 2025

VERV in +10.10% Uptrend, advancing for three consecutive days on April 24, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VERV advanced for three days, in of 192 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VERV's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 15, 2025. You may want to consider a long position or call options on VERV as a result. In of 56 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VERV just turned positive on April 15, 2025. Looking at past instances where VERV's MACD turned positive, the stock continued to rise in of 31 cases over the following month. The odds of a continued upward trend are .

VERV moved above its 50-day moving average on April 24, 2025 date and that indicates a change from a downward trend to an upward trend.

VERV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 50-day moving average for VERV moved below the 200-day moving average on April 17, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VERV entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.040) is normal, around the industry mean (14.305). P/E Ratio (0.000) is within average values for comparable stocks, (63.885). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.826). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (15.152) is also within normal values, averaging (254.869).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VERV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VERV is expected to report earnings to rise 11.57% to -64 cents per share on May 07

Verve Therapeutics VERV Stock Earnings Reports
Q1'25
Est.
$-0.65
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.11
The last earnings report on February 27 showed earnings per share of -57 cents, beating the estimate of -68 cents. With 1.66M shares outstanding, the current market capitalization sits at 511.46M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 617 603-0070
Employees
255
Web
https://www.vervetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEQAX13.23N/A
N/A
BNY Mellon Global Equity Income - A
HILRX20.20N/A
N/A
Hartford International Value R3
YASSX10.11N/A
N/A
AMG Yacktman Special Opportunities I
TSONX14.16N/A
N/A
Nuveen International Res Eq R6
OCSVX9.55-0.03
-0.31%
Optimum Small-Mid Cap Value C

VERV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-0.35%
BEAM - VERV
57%
Loosely correlated
-3.22%
CRSP - VERV
54%
Loosely correlated
-2.15%
ARWR - VERV
50%
Loosely correlated
-0.67%
RXRX - VERV
50%
Loosely correlated
-0.35%
PRME - VERV
50%
Loosely correlated
-3.43%
More